COMPANY PROFILE

Neurocare

Explore full profile

Neurocare group develops personalized digital therapies to improve patients' mental health

Munich, GermanyFounded 2015Health Tech & Medtech

Valuation $100–250M Last recorded · 2025

Revenue $1–10M Latest reported FY

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Neurocare

Neurocare Group is a global company that provides personalized mental health care and performance enhancement services. The company operates a network of clinics and offers services to both individuals and clinicians.

Neurocare's approach is centered around integrating technology and science into mental health treatment. They utilize a variety of methods, including psychotherapy, and neuromodulation techniques like the FDA-approved repetitive Transcranial Magnetic Stimulation (rTMS) and neurofeedback, to create personalized treatment plans. These plans are based on a comprehensive assessment of each individual's unique brain activity and psychological profile. The company treats a range of conditions, including depression, obsessive-compulsive disorder (OCD), ADHD, and sleep problems.

For clinicians and researchers, Neurocare provides the necessary hardware and software for therapy and research, along with training and support. This enables other professionals to adopt Neurocare's integrated approach in their own practices. It operates clinics and offers its digital therapy platform across multiple countries including the United States, Australia, the Netherlands, the UK & Ireland, and the Middle East.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2015
Headquarters: Munich, Germany
Employees: 159
Open positions: 7
Dealroom signal: 77.3/100
Industry: Health
Sub-industry: Health Platform
Sector: Health Tech & Medtech, Psychology, Pregnancy, Neurology, Mental Health, Patient Care, Neuromodulation and Neurostimulation, Brain Health, Horizon Europe
Business model: Marketplace & ecommerce, SaaS
Client focus: b2b, b2c
Investment activity: 2 companies, latest Jul 2025
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Feb 2025	$21M	$85M	TVM Capital Healthcare · Impact Expansion	↗
GROWTH EQUITY VC✓Equity / VC	Apr 2024	$17M	—	TVM Capital Healthcare	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	Profit	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Neurocare website traffic

Latest recorded traffic for Neurocare is 37K monthly website visits, up 12.1% over the last three months. Neurocare's team grew 3.9% over the past year.

Latest monthly visits37K 3-month web change+12.1% 1-year team growth+3.9%

Monthly website visitsDec 2018–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Bilanzbuchhalter (International) - IFRS-Konsolidierung & LucaNet (m/w/d)Munich, Germany, Western Europe, Europe · Logistics · Sep 1, 2026 Director of Clinical Services | PsychiatrySydney, New South Wales, Australia · Other · Aug 11, 2026 Product Marketing ManagerPhoenix, AZ · Marketing & Communication · Aug 3, 2026 Hybrid Psychiatrist | Consultations + TMS ProgramsSydney, New South Wales, Australia · Other · Jul 29, 2026 Specialist Neuromodulation Programs PsychologistSydney, New South Wales, Australia · Other · Jun 20, 2026 Specialist Psychiatrist | Consultations + TMS ProgramsSydney, New South Wales, Australia · Other · Jun 12, 2026

6 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OPOptoceuticsAdvancing non-invasive light technologies, based on gamma light therapy, to stimulate the brain and improve cognitive function	Kongens Lyngby, Denmark	Operational	15	$11K	—
MIMindpaxDeveloping a personalised platform for monitoring, diagnostics and treatment of Serious Mental Illnesses (MDD, BAD and Schizophrenia) allowing for personalised treatment	Munich, Germany	Operational
HMHealthy MindProviding virtual reality as a treatment for pain and anxiety in a healthcare establishments	Paris, France	Operational
NENeurabCreated a cognitive rehabilitation application on tablets for patients with acquired cognitive deficits	Rovereto, Italy	Operational
MHMango HealthAI-powered therapy platform offering personalized, anonymous support for OCD patients	San Francisco, United States	Closed
BRBrain+Developed with user experience in mind, Brain+ combines neuroscience with fun games that strive to improve mental capacity and quality of wellbeing	Copenhagen, Denmark	Operational
BOBioMinds Healthcare Sp. z o.o.A new way for neurological rehabilitation - system for remote rehabilitation operating in augmented and virtual reality for sick and healthy persons	Lublin, Poland	Operational
ACAmelia Virtual CareDeveloped a flexible Virtual Reality platform for therapists and healthcare professionals	Barcelona, Spain	Acquired